Regarding the sum of all currently available biochemical data for sGC and PDE-5, we suggest a model that shows the mechanism how PDE-5 inhibitors may lower portal pressure in cirrhotic portal hypertension (Figure 1B,C). The gene discussed is PDE5A; the disease is portal hypertension.